Back to Search

CRMD

CorMedix Inc.
Data: 2026-08-24
$8.28
Price
0.98%
Change
$14.96
52W High
$6.13
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Quick Stats
Aug 24, 2026

37.5

AI Score

EXTENDED

0.8

Volume Ratio

TBA

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

CRMD Stock Summary

Last updated Aug 24, 2026

CRMD is currently trading at $8.28, positioned below its 200-day moving average of $8.37, suggesting bearish momentum. The stock has a 52-week range of $6.125 to $14.96.

Technical Analysis: The 50-day moving average stands at $8.08, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 55.702, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.24, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CRMD at 37.5/100 with a EXTENDED recommendation.

CRMD (CorMedix Inc.) Indicators

Last updated Aug 24, 2026

Indicator Value
RSI(14) 55.702
CMF (20) -0.24
ROC (10) 9.695
ADX (14) 31.544
Indicator Value
MACD (12,26,9) 0.068
AROONOSC (14) 7.143
WILLAMS %R (14) -38.298
MFI (14) 61.379
CRMD Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CRMD Price vs Max Options Open Interest
CRMD Max Change In Options Open Interest

CRMD Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CRMD Daily Out of Money Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CRMD Daily In the Money Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

CRMD Most Active Options by Volume(near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

CorMedix Inc. is above the 50 Day SMA but below the 200 Day SMA — short-term strength within a longer-term downtrend (Mixed).

CRMD Moving Averages Analysis

CorMedix Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 24, 2026

CRMD (CorMedix Inc.) Simple Moving Averages

Moving Averages are last updated Aug 24, 2026

Days MA
10 7.91
20 7.68
30 7.82
50 8.08
100 7.93
200 8.37

CRMD Fundamental Analysis

P/E (Forward) 15.1745
P/E (Trailing) 3.7615
Market Cap ($) 639.1 million
Earnings/Share ($) 2.18
Net Profit Margin (%) 0.4049
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.488
EPS Estimate Next Year ($) 0.06
WallStreet Target Price ($) 15.40
Most Recent Quarter